BIOPHARMACEUTICALS and COVID-19: An Opportunity for Chemical Suppliers Webinar

September 21, 2021
Biologics, Biopharmaceuticals market

The rapid emergence of biologics, potentially further accelerated by the COVID-19 pandemic, is creating new opportunities for a variety of chemical products along the entire value chain. Indeed, various chemicals are not only used as key components of finished biologic drug dosage but also play an important role in the development and manufacturing of the drug itself.